» Authors » P Mogensen

P Mogensen

Explore the profile of P Mogensen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 238
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Madsen C, Mogensen P, Thomas N, Christensen D, Bygbjerg I, Mohan V, et al.
J Dev Orig Health Dis . 2014 Dec; 6(1):27-37. PMID: 25514893
Physical inactivity and low birth weight (LBW) may lead to an increased risk for developing type 2 diabetes. The extent to which LBW individuals may benefit from physical exercise training...
2.
Bjarkam C, Nielsen M, Glud A, Rosendal F, Mogensen P, Bender D, et al.
Br J Neurosurg . 2008 Dec; 22 Suppl 1:S9-12. PMID: 19085346
Large animal neuroscience enables the use of conventional clinical brain imagers and the direct use and testing of surgical procedures and equipment from the human clinic. The greater complexity of...
3.
Osther P, Grenabo L, Haraldsson G, HOLMBERG G, Lindell O, Mogensen P, et al.
Scand J Urol Nephrol . 2000 Jan; 33(6):372-81. PMID: 10636576
A set of simple guidelines for metabolic evaluation and medical/dietary management of patients with urolithiasis is presented. The evaluation scheme is based on the documented risk factors in the Nordic...
4.
Andreassen K, Dahl C, Andersen J, Rasmussen M, Jacobsen J, Mogensen P
Scand J Urol Nephrol . 1997 Jun; 31(3):245-8. PMID: 9249886
Eighty-four patients with solitary calyceal stones were treated with Extracorporeal Shock Wave Lithotripsy (ESWL) as first line monotherapy. The indications for treatment were pain in 51 patients (61%), infection in...
5.
Iversen P, Rasmussen F, Asmussen C, Christensen I, Eickhoff J, Klarskov P, et al.
J Urol . 1997 Mar; 157(3):929-34. PMID: 9072602
Purpose: We compared the effect of 560 mg. estramustine phosphate daily to placebo as a supplement to standard palliative therapy in patients with progressive disease after bilateral orchiectomy as first...
6.
Hansen B, Meyhoff H, Nordling J, Mensink H, Mogensen P, Larsen E
Scand J Urol Nephrol . 1996 Oct; 30(5):373-7. PMID: 8936626
In order to establish accurately the exact effect of any drug therapy for symptomatic benign prostatic hyperplasia (BPH) it is important to define the effect of placebo treatment. This effect...
7.
Jensen K, Jorgensen T, Mogensen P
Br J Urol . 1996 Aug; 78(2):213-8. PMID: 8813916
Objective: To investigate the long-term predictive value of urodynamics for the outcome of patients undergoing prostatic surgery for lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO) and...
8.
Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen N
Acta Neurol Scand . 1995 Aug; 92(2):116-21. PMID: 7484057
Objective: To investigate endogenous cerebrospinal fluid catecholamines in Parkinson's disease. Material And Methods: Basal concentrations of free norepinephrine (NE), dopamine (DA), epinephrine (E), 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylalanine (DOPA) in...
9.
Jorgensen J, Jensen K, Mogensen P
Scand J Urol Nephrol . 1994 Jun; 28(2):163-9. PMID: 7524145
In a 7-year study of 178 randomly selected healthy men older than 50, data were respectively obtained concerning treatment for benign prostatic hypertrophy (BPH) and overall morbidity and mortality. Plain...
10.
Mogensen P, Andersen J
Scand J Urol Nephrol Suppl . 1994 Jan; 157:159-63. PMID: 7939448
The use of a second generation lithotriptor (Siemens Lithostar) for ESWL treatment of 199 consecutively referred patients with ureteral calculi is evaluated. Follow up data were available in all patients....